首页> 美国卫生研究院文献>Elsevier Sponsored Documents >β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
【2h】

β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function

机译:肾脏中的β3肾上腺素受体可能是肾功能交感调节的新参与者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To date, the study of the sympathetic regulation of renal function has been restricted to the important contribution of β1- and β2-adrenergic receptors (ARs). Here we investigate the expression and the possible physiologic role of β3-adrenergic receptor (β3-AR) in mouse kidney. The β3-AR is expressed in most of the nephron segments that also express the type 2 vasopressin receptor (AVPR2), including the thick ascending limb and the cortical and outer medullary collecting duct. Ex vivo experiments in mouse kidney tubules showed that β3-AR stimulation with the selective agonist BRL37344 increased intracellular cAMP levels and promoted 2 key processes in the urine concentrating mechanism. These are accumulation of the water channel aquaporin 2 at the apical plasma membrane in the collecting duct and activation of the Na-K-2Cl symporter in the thick ascending limb. Both effects were prevented by the β3-AR antagonist L748,337 or by the protein kinase A inhibitor H89. Interestingly, genetic inactivation of β3-AR in mice was associated with significantly increased urine excretion of water, sodium, potassium, and chloride. Stimulation of β3-AR significantly reduced urine excretion of water and the same electrolytes. Moreover, BRL37344 promoted a potent antidiuretic effect in AVPR2-null mice. Thus, our findings are of potential physiologic importance as they uncover the antidiuretic effect of β3-AR stimulation in the kidney. Hence, β3-AR agonism might be useful to bypass AVPR2-inactivating mutations.
机译:迄今为止,对肾功能的交感调节的研究仅限于β1-和β2-肾上腺素能受体(ARs)的重要贡献。在这里,我们研究β3-肾上腺素能受体(β3-AR)在小鼠肾脏中的表达及其可能的生理作用。 β3-AR在大多数肾单位节段中表达,这些节段也表达2型加压素受体(AVPR2),包括上肢粗大,皮质和髓外集合管。小鼠肾小管的体外实验表明,选择性激动剂BRL37344刺激β3-AR可以增加细胞内cAMP水平并促进尿液浓缩机制中的两个关键过程。这些是水通道水通道蛋白2在收集导管的顶质膜上的积累和在厚的上升肢中Na-K-2Cl转运体的活化。 β3-AR拮抗剂L748,337或蛋白激酶A抑制剂H89阻止了这两种作用。有趣的是,小鼠中β3-AR的基因失活与尿液中水,钠,钾和氯的排泄显着增加有关。刺激β3-AR可以显着减少尿液中水分和相同电解质的排泄。此外,BRL37344在AVPR2无小鼠中促进了强效的利尿作用。因此,我们的发现揭示了β3-AR刺激肾脏的抗利尿作用,因此具有潜在的生理重要性。因此,β3-AR激动可能有助于绕过AVPR2失活突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号